These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cortical abnormalities in Alzheimer's disease. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G. Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378 [Abstract] [Full Text] [Related]
4. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18. Zahn R, Juengling F, Bubrowski P, Jost E, Dykierek P, Talazko J, Huell M. Psychiatry Res; 2004 Dec 15; 132(2):159-72. PubMed ID: 15598550 [Abstract] [Full Text] [Related]
5. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Am J Psychiatry; 2002 May 15; 159(5):738-45. PubMed ID: 11986126 [Abstract] [Full Text] [Related]
6. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Bird TD, Stranahan S, Sumi SM, Raskind M. Ann Neurol; 1983 Sep 15; 14(3):284-93. PubMed ID: 6227276 [Abstract] [Full Text] [Related]
8. Frequency and clinical characteristics of early-onset dementia in consecutive patients in a memory clinic. Shinagawa S, Ikeda M, Toyota Y, Matsumoto T, Matsumoto N, Mori T, Ishikawa T, Fukuhara R, Komori K, Hokoishi K, Tanabe H. Dement Geriatr Cogn Disord; 2007 Sep 15; 24(1):42-7. PubMed ID: 17495475 [Abstract] [Full Text] [Related]
13. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Juh R, Pae CU, Lee CU, Yang D, Chung Y, Suh T, Choe B. Neurosci Res; 2005 Jul 15; 52(3):211-9. PubMed ID: 15927722 [Abstract] [Full Text] [Related]
14. [Symptom severity and symptom progression in Alzheimer's disease-- comparison between two cases with early and late onset]. Haupt M, Kurz A, Pollmann S, Romero B. Nervenarzt; 1992 Sep 15; 63(9):561-5. PubMed ID: 1407227 [Abstract] [Full Text] [Related]
16. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D. Arch Neurol; 2005 Nov 15; 62(11):1728-33. PubMed ID: 16286547 [Abstract] [Full Text] [Related]
17. Differential hypometabolism patterns according to mild cognitive impairment subtypes. Jauhiainen AM, Kangasmaa T, Rusanen M, Niskanen E, Tervo S, Kivipelto M, Vanninen RL, Kuikka JT, Soininen H. Dement Geriatr Cogn Disord; 2008 Nov 15; 26(6):490-8. PubMed ID: 18987469 [Abstract] [Full Text] [Related]
18. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease. Kessler J, Mielke R, Grond M, Herholz K, Heiss WD. Int J Neurosci; 2000 Nov 15; 104(1-4):1-15. PubMed ID: 11011970 [Abstract] [Full Text] [Related]
20. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A. Neurology; 2005 Jan 11; 64(1):102-7. PubMed ID: 15642911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]